Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lutropin alfa added in the mid-follicular phase for women at risk of poor ovarian response undergoing controlled ovarian stimulation
2005-002229-30Phase 2Completed
- Sponsor
- Serono
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of lutropin alfa in female infertility (2 arms), sponsored by Serono. Primary endpoints: Total number of oocytes retrieved, Number of metaphase II oocytes retrieved and 1 more. Started Jul 2005; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2005-002229-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002229-30.